moxifloxacin has been researched along with fesoterodine in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (fesoterodine) | Trials (fesoterodine) | Recent Studies (post-2010) (fesoterodine) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 204 | 79 | 156 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gandelman, K; Malhotra, B; Sachse, R; Wood, N | 1 |
1 review(s) available for moxifloxacin and fesoterodine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for moxifloxacin and fesoterodine
| Article | Year |
|---|---|
Thorough QT study of the effect of fesoterodine on cardiac repolarization.
Topics: Aza Compounds; Benzhydryl Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Least-Squares Analysis; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Muscarinic Antagonists; Quinolines; Urinary Bladder, Overactive | 2010 |